Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 5Phase 1 5Phase NA 4Phase 3 3

Status

Recruiting 2Withdrawn 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myeloid, Acute 1Carcinoma, Hepatocellular 1Cancer Pain 1Breast Neoplasms 1Breakthrough Pain 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 259Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 146Surgical Procedures, Operative 135Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Specimen Handling 79Radiotherapy, Intensity-Modulated 79Colonoscopy 79Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Infusions, Intravenous × Clear all
NCT07243691 2025-11-24

Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma

Sir Run Run Shaw Hospital

Phase NA Recruiting
33 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06490718 2025-09-08

Comparing Quality of Recovery Between ESPB and IV Lidocaine After Major Breast Cancer Surgery

Chinese University of Hong Kong

Phase NA Completed
80 enrolled
Breast

Breast Neoplasms

NCT06232694 2024-01-31

Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
54 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05053308 2023-08-07

Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement

Seoul National University

Phase NA Withdrawn

Cancer Pain, Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡